DAVID SALOFF

Corporate Board Profile

Tech Score: 100/100

← Back to All Directors

Software Technology Evidence

1 mention(s) identify DAVID SALOFF as having software/technology expertise.

Company Filing Date Evidence Reason
GT Biopharma, Inc. 2011-07-14 In 1992, Mr. Saloff founded Electropharmacology, Inc., and was responsible for the design, development and subsequent FDA clearance of the SofPulse device. Has experience in the design and development of medical technology, indicating relevant technical skills.

GT Biopharma, Inc.

Filing Date Source Excerpt
2011-07-14 In 1992, Mr. Saloff founded Electropharmacology, Inc., and was responsible for the design, development and subsequent FDA clearance of the SofPulse device.

Data sourced from SEC filings. Last updated: 2025-07-01